Download PDF
1 / Pages

Other users also viewed these articles

Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS) Marco Garrido-Cumbrera; Denis Poddubnyy; Fernando Sommerfleck; Christine Bundy; Souzi Makri; José Correa-Fernández; Shashank Akerkar; Jo Lowe; Elie Karam; Victoria Navarro-Compán;
Reumatol Clin. 2024;20:547-54
Recommendations of the Mexican College of Rheumatology for the management of spondyloarthritis Greta Reyes-Cordero; Favio Enríquez-Sosa; Citlallyc Gomez-Ruiz; Verónica Gonzalez-Diaz; José Dionisio Castillo-Ortiz; Sergio Duran-Barragán; J. Santos Duran-Ortiz; Rolando Espinosa-Morales; Jorge I. Gamez-Nava; Laura Gonzalez-Lopez; Bernardo Julian-Martínez; Angélica Mendoza-Fuentes; Cesar Ramos-Remus; Cesar Pacheco-Tena; Ruben Burgos-Vargas;
Reumatol Clin. 2021;17:37-45
Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab Juan José Lerma Garrido; Antonio Gracia Pérez; Antonio Pérez Torres; Amalia Rueda Cid; Clara Molina Almela; María Dolores Pastor Cubillo; Cristina Campos Fernández; Isabel Balaguer Trull; Loreto Carmona; Javier Calvo Catalá;
Reumatol Clin. 2022;18:25-9